XML 50 R39.htm IDEA: XBRL DOCUMENT v3.23.3
Organization and Description of Business (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Feb. 01, 2023
Jan. 13, 2023
Jun. 30, 2022
Jan. 31, 2023
Nov. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Subsidiary, Sale of Stock [Line Items]                    
Cash, cash equivalents, restricted cash and marketable securities           $ 45,500   $ 45,500   $ 76,200
Net loss           13,237 $ 20,425 47,898 $ 54,724  
Net cash used in operating activities               (45,105) (72,053)  
Accumulated deficit           566,212   566,212   518,314
Working capital           $ 57,900   57,900   $ 98,000
Proceeds from sale of business               17,000 $ 50,000  
Left-Heart Access Portfolio                    
Subsidiary, Sale of Stock [Line Items]                    
Contingent consideration received from sales               $ 6,100    
Held-for-sale | Left-Heart Access Portfolio                    
Subsidiary, Sale of Stock [Line Items]                    
Proceeds from sale of business   $ 17,000 $ 50,000 $ 17,000 $ 20,000          
Indemnity escrow account, amount     $ 4,000 $ 1,400 $ 1,600          
Indemnity escrow account, term     18 months              
Milestone consideration, period 4 years   4 years              
Held-for-sale | Left-Heart Access Portfolio | Year one                    
Subsidiary, Sale of Stock [Line Items]                    
Milestone consideration, royalty percentage 100.00%   100.00%              
Held-for-sale | Left-Heart Access Portfolio | Year two                    
Subsidiary, Sale of Stock [Line Items]                    
Milestone consideration, royalty percentage 75.00%   75.00%              
Held-for-sale | Left-Heart Access Portfolio | Year three                    
Subsidiary, Sale of Stock [Line Items]                    
Milestone consideration, royalty percentage 50.00%   50.00%              
Held-for-sale | Left-Heart Access Portfolio | Year four                    
Subsidiary, Sale of Stock [Line Items]                    
Milestone consideration, royalty percentage 50.00%   50.00%